Evaluation of N-acetyl-beta-glucosaminidase in two groups of renal transplant recipients undergoing conventional and cyclosporin A therapy: 48 months follow-up

MeSH terms

• Acetylglucosaminidase / urine*
• Adult
• Cyclosporins / adverse effects*
• Follow-Up Studies
• Hexosaminidases / urine*
• Humans
• Immunosuppressive Agents / adverse effects
• Kidney / drug effects*
• Kidney Transplantation
• Middle Aged
• Time Factors